AU633940B2 - Method for stimulating proliferation of peripheral blood lymphocytes - Google Patents

Method for stimulating proliferation of peripheral blood lymphocytes Download PDF

Info

Publication number
AU633940B2
AU633940B2 AU59182/90A AU5918290A AU633940B2 AU 633940 B2 AU633940 B2 AU 633940B2 AU 59182/90 A AU59182/90 A AU 59182/90A AU 5918290 A AU5918290 A AU 5918290A AU 633940 B2 AU633940 B2 AU 633940B2
Authority
AU
Australia
Prior art keywords
cells
culturing
period
days
peripheral blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59182/90A
Other languages
English (en)
Other versions
AU5918290A (en
Inventor
Teruaki Sekine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23515405&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU633940(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of AU5918290A publication Critical patent/AU5918290A/en
Application granted granted Critical
Publication of AU633940B2 publication Critical patent/AU633940B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • A61K40/4202—Receptors, cell surface antigens or cell surface determinants
    • A61K40/421—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0646—Natural killers cells [NK], NKT cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/124—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells the cells being hematopoietic, bone marrow derived or blood cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/44—Thiols, e.g. mercaptoethanol
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/33—Insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU59182/90A 1989-07-21 1990-07-20 Method for stimulating proliferation of peripheral blood lymphocytes Ceased AU633940B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38394289A 1989-07-21 1989-07-21
US383942 1989-07-21

Publications (2)

Publication Number Publication Date
AU5918290A AU5918290A (en) 1991-01-24
AU633940B2 true AU633940B2 (en) 1993-02-11

Family

ID=23515405

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59182/90A Ceased AU633940B2 (en) 1989-07-21 1990-07-20 Method for stimulating proliferation of peripheral blood lymphocytes

Country Status (7)

Country Link
EP (1) EP0409655A3 (enExample)
JP (1) JP3056230B2 (enExample)
AU (1) AU633940B2 (enExample)
CA (1) CA2021500C (enExample)
GR (1) GR1001034B (enExample)
IE (1) IE902662A1 (enExample)
ZA (1) ZA905735B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2981486B2 (ja) * 1988-06-14 1999-11-22 メディカル・バイオロジー・インスティチュート 哺乳動物の免疫系研究方法
US5725855A (en) * 1991-04-05 1998-03-10 The United States Of America As Represented By The Department Of Health And Human Services Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
WO1992017567A1 (en) * 1991-04-05 1992-10-15 Regents Of The University Of Minnesota Method of enhancing the immunotherapeutic activity of immune cells by depletion/positive selection of cell subsets
IE922233A1 (en) * 1991-07-10 1993-01-13 Augusto C Ochoa Short-term anti-cd3 stimulation of lymphocytes to increase¹their in vivo activity
WO1995032729A1 (en) * 1994-05-31 1995-12-07 Augusto Carlos Ochoa Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity
US6511848B2 (en) 1996-04-17 2003-01-28 Winfried Albert Process for producing and multiplying lymphocytes
JP3381224B2 (ja) * 1996-04-17 2003-02-24 ベーリンガー マンハイム ゲゼルシャフト ミット ベシュレンクテル ハフツング リンパ球を生産し、そして増加させる方法
WO1998002175A1 (en) * 1996-07-15 1998-01-22 Teruaki Sekine Remedies/preventives for viral infections, process for preparing the same, and method for preventing/treating viral infections
SE511143C2 (sv) 1997-12-30 1999-08-09 Sca Hygiene Paper Ab Metod att framställa ett papper uppvisande en tredimensionellt mönster
JP2001354575A (ja) 2000-06-09 2001-12-25 Human Tekku:Kk 癌の再発予防法および癌の再発予防用活性化リンパ球を含む製剤、ならびにそれらの細胞の凍結および加工委・受託システム
JP4917201B2 (ja) * 2000-12-04 2012-04-18 株式会社リンフォテック 臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤、臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤、臍帯血移植後の腫瘍および各種感染症の予防・治療用製剤ならびに臍帯血移植後の移植臍帯血幹細胞の生着促進用製剤の製造方法。
US20040086492A1 (en) * 2001-03-05 2004-05-06 Hideo Yanai Method of treating tumor and consignment system of proliferating and processing activated lymphocytes to be used in parallel to pdt
DE10120505A1 (de) * 2001-04-26 2002-11-07 Rudolf Wank Verwendung von stimulierten mononukleären Zellen des peripheren Blutes zur Behandlung von Krebserkrankungen
TW201043699A (en) 2002-03-25 2010-12-16 Takara Bio Inc Process for producing cytotoxic lymphocyte
JP4562353B2 (ja) * 2002-04-08 2010-10-13 株式会社リンフォテック Ｈｌａ一致他人由来活性化リンパ球を含有してなる腫瘍・感染症および自己免疫疾患の予防・治療用製剤
US20070025961A1 (en) * 2003-06-03 2007-02-01 Kenzo Bamba Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf
US8927273B2 (en) 2003-08-22 2015-01-06 Takara Bio Inc. Process for producing cytotoxic lymphocytes
JP2006143709A (ja) * 2004-10-20 2006-06-08 Lymphotec:Kk 薬剤耐性原生生物感染症の治療もしくは予防用製剤、該製剤の調製用キットおよび調製方法、薬剤耐性原生生物感染症の治療方法
WO2007020880A1 (ja) * 2005-08-17 2007-02-22 Takara Bio Inc. リンパ球の製造方法
TW200817680A (en) * 2006-06-02 2008-04-16 Glaxosmithkline Biolog Sa Method
KR101133185B1 (ko) * 2008-07-29 2012-04-06 서울대학교병원 자연살해세포의 증식방법
JP2011001315A (ja) 2009-06-19 2011-01-06 Cellex Corp 膵臓癌の免疫療法剤
WO2018124119A1 (ja) * 2016-12-27 2018-07-05 住友化学株式会社 染色体の異常の検出方法および誘発性を評価する方法
AU2019215034C1 (en) 2018-02-01 2022-01-06 Nkmax Co., Ltd. Method of producing natural killer cells and composition for treating cancer
EP4070855B1 (en) 2019-11-01 2025-12-24 Kyoto Prefectural Public University Corporation B-cell antibody receptor and use thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4485089A (en) * 1988-10-21 1990-05-14 Brigham And Women's Hospital Activation and growth of human tumor-infiltrating lymphocytes using antibodies to cd3 or tcr

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2529321B2 (ja) * 1986-04-28 1996-08-28 エンドトロニックス インコーポレーテッド 白血球を培養する方法
WO1988000970A2 (en) * 1986-08-08 1988-02-11 Regents Of The University Of Minnesota Method of culturing leukocytes
DE3634017A1 (de) * 1986-10-06 1988-04-14 Max Planck Gesellschaft Verfahren zur aktivierung und vermehrung von t-zellen, insbesondere von deren subpopulationen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4485089A (en) * 1988-10-21 1990-05-14 Brigham And Women's Hospital Activation and growth of human tumor-infiltrating lymphocytes using antibodies to cd3 or tcr

Also Published As

Publication number Publication date
GR1001034B (el) 1993-03-31
ZA905735B (en) 1992-03-25
EP0409655A2 (en) 1991-01-23
CA2021500A1 (en) 1991-01-22
JP3056230B2 (ja) 2000-06-26
GR900100551A (enExample) 1991-12-10
AU5918290A (en) 1991-01-24
CA2021500C (en) 1995-06-13
EP0409655A3 (en) 1992-04-15
JPH0380076A (ja) 1991-04-04
IE902662A1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
CA2021500C (en) Method for stimulating proliferation of peripheral blood lymphocytes
US20210115401A1 (en) Methods and Materials for the Generation of Regulatory T Cells
CN107922925B (zh) 用于自然杀伤细胞扩增的方法
AU694304B2 (en) Method for making a medicament for treating secondary immunodeficiency
EP2573166B1 (en) Methods for preparing T-cells for cell therapy
JP2006524991A (ja) 抗原特異的ｔ細胞の作製および単離の方法
Nham et al. Ex vivo-expanded natural killer cells derived from long-term cryopreserved cord blood are cytotoxic against primary breast cancer cells
CN101506356A (zh) 用于免疫治疗的活化淋巴细胞的制备方法
WO1991005037A1 (en) Extracellular matrix protein adherent t cells
CN105101978A (zh) Nk细胞强化型血液制剂的制造方法
US20210361711A1 (en) CIML NK cells and Methods Therefor
KR20210079381A (ko) Ciml nk 세포 및 이를 위한 방법(ciml nk cells and methods therefor)
JP2002171966A (ja) 臍帯血由来活性化リンパ球及び該リンパ球を主成分とする製剤ならびに該製剤の製造方法、該製剤調整用キット。
AU2021447912A1 (en) Method for producing tumor-infiltrating t-lymphocytes (til) and their use as cellular therapeutics for the treatment of human tumors
WO1990004633A1 (en) ACTIVATION AND GROWTH OF HUMAN TUMOR-INFILTRATING LYMPHOCYTES USING ANTIBODIES TO CD3 OR TcR
Nordon et al. Ex vivo manipulation of cell subsets for cell therapies
Liu et al. Growth stimulation of tumor-specific cytotoxic T lymphocytes on concanavalin A-immobilized carrier beads
CN120366214A (zh) 基于金属离子调控的干性记忆t细胞体外诱导与扩增方法
Lotzová Natural Killer Cells: Odyssey from Laboratory Artifact to Clinical Reality
MXPA97003626A (en) Method for manufacturing a medicine to treat second secondary immunodeficiency